|
| 36608382 | Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors. | Gynecol Oncol | 2023 |
| 37397238 | Gynecologic Oncology Reports: 2022 and beyond. | Gynecol Oncol Rep | 2023 |
| 36910449 | Condyloma lata mimicking vulvar carcinoma in an immunocompromised patient: A case report. | Gynecol Oncol Rep | 2023 |
| 35216968 | Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study. | Am J Obstet Gynecol | 2022 |
| 35531356 | Editorial. | Gynecol Oncol Rep | 2022 |
| 35719321 | Ridiculously good writing: How to write like a pro and publish like a boss. | Gynecol Oncol Rep | 2022 |
| 35711730 | Optimizing post-operative opiate prescribing following gynecologic surgery. | Gynecol Oncol Rep | 2022 |
| 36405306 | Society of Gynecologic Oncology Journal Club: Controversial conversations in gynecologic cancer - Navigating maintenance therapy for homologous recombinant proficient ovarian cancer. | Gynecol Oncol Rep | 2022 |
| 36357974 | Endometrial Hyperplasia. | Obstet Gynecol | 2022 |
| 33577226 | MLH1/PMS2-deficient Endometrial Carcinomas in a Universally Screened Population: MLH1 Hypermethylation and Germline Mutation Status. | Int J Gynecol Pathol | 2022 |
| 35071723 | Beneficial effects of exercise on chemotherapy-induced peripheral neuropathy and sleep disturbance: A review of literature and proposed mechanisms. | Gynecol Oncol Rep | 2022 |
| 32877271 | "Moving Away From Cancer" Prospective Exercise Trial for Female Rural Cancer Survivors: How Can We Step It Up? | JCO Oncol Pract | 2021 |
| 34548162 | Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study. | Gynecol Oncol | 2021 |
| 34413086 | Characteristics of Immune Memory and Effector Activity to Cancer-Expressed MHC Class I Phosphopeptides Differ in Healthy Donors and Ovarian Cancer Patients. | Cancer Immunol Res | 2021 |
| 33105279 | Development and Impact of an Institutional Enhanced Recovery Program on Opioid Use, Length of Stay, and Hospital Costs Within an Academic Medical Center: A Cohort Analysis of 7774 Patients. | Anesth Analg | 2021 |
| 33390325 | A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer. | Gynecol Oncol | 2021 |
| 33037555 | Perioperative Impact of Widespread Implementation of an Enhanced Recovery Protocol on Short-term Outcomes in Cancer Patients. | J Gastrointest Surg | 2021 |
| 32490124 | Evaluation of breast screening strategies in a high risk breast and ovarian cancer clinic. | Gynecol Oncol Rep | 2020 |
| 31948730 | Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy? | Gynecol Oncol | 2020 |
| 33004542 | Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer. | J Immunother Cancer | 2020 |
| 32771986 | Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion. | Int J Gynecol Cancer | 2020 |
| 32656916 | Mechanisms to increase cascade testing in hereditary breast and ovarian cancer: Impact of introducing standardized communication aids into genetic counseling. | J Obstet Gynaecol Res | 2020 |
| 32984493 | Neoadjuvant chemotherapy with paclitaxel/carboplatin/bevacizumab in advanced vulvar cancer: Time to rethink standard of care? | Gynecol Oncol Rep | 2020 |
| 32382648 | Optimal age for genetic cancer predisposition testing in hereditary <i>SMARCA4</i> Ovarian Cancer Families: How young is too young? | Gynecol Oncol Rep | 2020 |
| 29485423 | Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African American Women: A Study of PD-L1 and IDO in 112 Cases From the African American Cancer Epidemiology Study (AACES). | Int J Gynecol Pathol | 2019 |
| 31796975 | When to Worry about Cancer: Concurrent Carcinoma and Recurrence in Borderline Ovarian Tumors. | South Med J | 2019 |
| 31623857 | Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG study. | Gynecol Oncol | 2019 |
| 31305484 | Practical Cancer Genetics and Genomics in Women's Health. | Clin Obstet Gynecol | 2019 |
| 31015198 | Phase II Trial of Chemopreventive Effects of Levonorgestrel on Ovarian and Fallopian Tube Epithelium in Women at High Risk for Ovarian Cancer: An NRG Oncology Group/GOG Study. | Cancer Prev Res (Phila) | 2019 |
| 30775416 | Evaluation of screening and risk-reducing surgery for women followed in a high-risk breast/ovarian cancer clinic: it is all about the tubes in BRCA mutation carriers. | Gynecol Oncol Rep | 2019 |
| 30706980 | Cases and evidence for panel testing in cancer genetics: Is site-specific testing dead? | J Genet Couns | 2019 |
| 30993488 | Genetic counseling referral for ovarian cancer patients: a call to action. | Fam Cancer | 2019 |
| 30376964 | Missing information in statewide and national cancer databases: Correlation with health risk factors, geographic disparities, and outcomes. | Gynecol Oncol | 2019 |
| 30374533 | Enhanced recovery program for minimally invasive and vaginal urogynecologic surgery. | Int Urogynecol J | 2019 |
| 29428283 | Hereditary Cancers in Gynecology: What Physicians Should Know About Genetic Testing, Screening, and Risk Reduction. | Obstet Gynecol Clin North Am | 2018 |
| 29892684 | Vaginal sarcoidosis without other organ involvement in a patient with a history of endometrial cancer: A case report. | Gynecol Oncol Rep | 2018 |
| 29807694 | Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: An NRG oncology group/gynecologic oncology group study. | Gynecol Oncol | 2018 |
| 30128349 | Intussusception as a rare cause of bowel obstruction in a woman with recurrent ovarian cancer. | Gynecol Oncol Rep | 2018 |
| 29958926 | Clinicopathologic characterization of breast carcinomas in patients with non-BRCA germline mutations: results from a single institution's high-risk population. | Hum Pathol | 2018 |
| 29977988 | Endometrial cancer in an increasingly obese population: Exploring alternative options when surgery may not cut it. | Gynecol Oncol Rep | 2018 |
| 29778506 | Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study. | Gynecol Oncol | 2018 |
| 29559741 | Indoleamine 2,3-dioxygenase in endometrial cancer: a targetable mechanism of immune resistance in mismatch repair-deficient and intact endometrial carcinomas. | Mod Pathol | 2018 |
| 27984238 | PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinomas, Including Lynch Syndrome-associated and MLH1 Promoter Hypermethylated Tumors. | Am J Surg Pathol | 2017 |
| 28411145 | Current and future role of genetic screening in gynecologic malignancies. | Am J Obstet Gynecol | 2017 |
| 29464034 | Analysis of the circular RNA transcriptome in endometrial cancer. | Oncotarget | 2017 |
| 29050779 | Transcriptome landscape of long intergenic non-coding RNAs in endometrial cancer. | Gynecol Oncol | 2017 |
| 28655413 | The impact of physician burnout on clinical and academic productivity of gynecologic oncologists: A decision analysis. | Gynecol Oncol | 2017 |
| 27001221 | Rates of human papillomavirus vaccine uptake amongst girls five years after introduction of statewide mandate in Virginia. | Am J Obstet Gynecol | 2016 |
| 26524722 | Body mass index and mortality in endometrial cancer: A systematic review and meta-analysis. | Gynecol Oncol | 2016 |
| 26523542 | Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry. | Am J Surg Pathol | 2016 |